Patent · US Active

Microbiome-based diagnosis, prediction and treatment of relapsing obesity

US12161679B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 12, 2021
Grant dateDec 10, 2024
Priority date—
Expiry dateSep 10, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA23V2250/2116
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of analyzing the likelihood of weight regain in a subject who has reached a target weight by practicing a weight loss program is disclosed. The method comprises determining an amount or presence of at least one microbe and/or product thereof in the gut microbiome of the subject, wherein the amount of the at least one microbe is altered during a prior weight gain period of the subject to reach a level representative of an obese subject and further wherein the amount of the at least one microbe is retained at the level following the weight loss program, wherein the amount or presence of the at least one microbe or product thereof is predictive of weight regain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.